According to Endo International 's latest financial reports the company's total assets are $5.13 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $5.13 B | -10.78% |
2022-12-31 | $5.75 B | -34.33% |
2021-12-31 | $8.76 B | -5.37% |
2020-12-31 | $9.26 B | -1.33% |
2019-12-31 | $9.38 B | -7.33% |
2018-12-31 | $10.13 B | -12.92% |
2017-12-31 | $11.63 B | -18.49% |
2016-12-31 | $14.27 B | -26.23% |
2015-12-31 | $19.35 B | 78.77% |
2014-12-31 | $10.82 B | 64.7% |
2013-12-31 | $6.57 B | 0.05% |
2012-12-31 | $6.56 B | -9.93% |
2011-12-31 | $7.29 B | 86.4% |
2010-12-31 | $3.91 B | 57.2% |
2009-12-31 | $2.48 B | 30.39% |
2008-12-31 | $1.90 B | 12.1% |
2007-12-31 | $1.70 B | 21.91% |
2006-12-31 | $1.39 B | 1.82% |
2005-12-31 | $1.37 B | 44.77% |
2004-12-31 | $0.94 B | 25.68% |
2003-12-31 | $0.75 B | 46.96% |
2002-12-31 | $0.51 B | 8.91% |
2001-12-31 | $0.47 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Zogenix ZGNX | N/A | N/A | ๐บ๐ธ USA |
Cara Therapeutics
CARA | $0.12 B | -97.55% | ๐บ๐ธ USA |